Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.73 - $4.73 $91,700 - $158,880
33,590 New
33,590 $99,000
Q3 2023

Nov 13, 2023

BUY
$4.6 - $7.95 $203,922 - $352,431
44,331 New
44,331 $203,000
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $457,975 - $680,990
49,780 Added 263.71%
68,657 $679,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $27,667 - $51,514
4,837 Added 34.45%
18,877 $201,000
Q1 2022

May 13, 2022

BUY
$7.46 - $14.14 $104,738 - $198,525
14,040 New
14,040 $137,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.